Subscribe To
Jasper therapeutics announces positive follow-up clinical data from investigator-sponsored study of briquilimab conditioning in fanconi anemia patients at the 2023 transplantation & cellular therapy m
Both Fanconi Anemia patients treated with briquilimab successfully engrafted with neutrophil engraftment within 11 days 100% total donor chimerism was...
February 17, 2023, 1:10 pm
Global antibody-mediation rejection prevention market to rise at a staggering 16% cagr until 2033; mabs to be frequently deployed treatment approach: future market insights, inc. study
The antibody-mediated rejection prevention market in the United States and United Kingdom is a rapidly growing segment of the healthcare industry. Ant...
February 6, 2023, 10:30 am
Omeros: worst has been priced in, we like its igan pipeline, initiating with a buy
Omeros corporation's hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA) ...
February 4, 2023, 8:33 am
Jasper therapeutics, inc. reports inducement grant under nasdaq listing rule 5635(c)(4)
REDWOOD CITY, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on d...
February 3, 2023, 9:05 pm
Jasper therapeutics announces closing of public offering of common stock and full exercise of underwriters’ option to purchase additional shares
REDWOOD CITY, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on d...
January 27, 2023, 6:10 pm
Ishlt2023 meeting final program announced
43rd Annual Meeting & Scientific Sessions features the latest in advanced heart and lung disease science and clinical practice. Chicago, USA, Jan. 20,...
January 20, 2023, 7:00 pm
Jasper therapeutics shares jump after announcing new clinical data
Shares of Jasper Therapeutics Inc. JSPR, +318.31% soared 283% in trading on Tuesday after the company said in a news release that its experimental the...
January 3, 2023, 10:40 am
Alaska man misses heart transplant surgery after winter storm cancels his flight to seattle
I think I cried more that day than I have in my life,” said Patrick Holland, who is battling congestive heart failure. Read Full Story at source (ma...
December 30, 2022, 6:44 pm
Man misses heart transplant due to flight disruptions: ‘cried more that day than…’
But his flight was cancelled, Holland’s wife wrote on the Facebook page “Patrick’s transplant Jou...
December 30, 2022, 10:59 am
Man misses heart transplant over canceled flight due to winter storm
The Alaska man is battling congestive heart failure Doctors in Seattle reportedly gave him an eight-hour window to get to the hospital The heart went ...
December 30, 2022, 3:29 am
Alaska man with congestive heart failure blocked from getting transplant due to winter storm elliott
Alaska man with congestive heart failure blocked from getting transplant due to winter storm Elliott �...
December 29, 2022, 9:29 pm
Canceled flight to seattle costs alaska man chance for heart transplant
The severe winter storm that has left US air travel in a frenzy since Christmas weekend had a particularly devastating effect on an Alaskan man who wa...
December 29, 2022, 7:44 pm
Canceled flight to seattle costs patrick holland chance for heart transplant
An Alaska man in need of a heart transplant had to give up his opportunity to receive the life-saving o...
December 29, 2022, 7:29 pm
Nexcella, inc announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car t-cell meeting
Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...
December 28, 2022, 1:05 pm
Nexcella, inc., a subsidiary of immix biopharma, announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car
Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...
December 28, 2022, 1:00 pm
Nexcella, inc., a subsidiary of immix biopharma, announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car
Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...
December 28, 2022, 1:00 pm
Nexcella, inc., a subsidiary of immix biopharma, announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car
Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...
December 28, 2022, 1:00 pm
Nexcella, inc., a subsidiary of immix biopharma, announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car
Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...
December 28, 2022, 1:00 pm
Nexcella, inc., a subsidiary of immix biopharma, announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car
Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...
December 28, 2022, 1:00 pm
Nexcella, inc., a subsidiary of immix biopharma, announces poster presentation at the european society for blood and marrow transplantation and european hematology association 5th annual european car
Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands Februa...
December 28, 2022, 1:00 pm